Medtronic reports rise in Q2 FY 2025 net income to $1.27bn
Worldwide revenue for the quarter reached $8.403bn, an uptick of 5.3% as reported and 5% on an organic basis.
Medical Devices
EndoTheia completes trial of FlexStone device for kidney stone removal
Augmedics’ xvision system registration method gains FDA clearance
Dexcom invests $75m in ŌURA to forge partnership
Halma acquires Lamidey Noury Medical to bolster healthcare sector offerings
NHS to expand digital eye screening programme
Tivic hits enrolment target for vagus nerve stimulation trial
Solventum introduces 3M Clarity Precision Grip Attachments for aligner treatment
